Pana Sharma
President and CEO of Lantern Pharma
Replay available
Lantern Pharma Inc. (NASDAQ: LTRN) Q4 2025 earnings conference call, held 2026-03-30. Replay captured from the company's public earnings webcast.

President and CEO of Lantern Pharma
Chief Financial Officer of Lantern Pharma
Watch the replay and follow the connected company analysis, news, and investor updates for Lantern Pharma Inc..
WEBVTT 00:00:00.031 -- 00:00:05.142 Good afternoon and welcome to our fourth quarter and year-end 2025 earnings 00:00:05.142 -- 00:00:10.795 call. As a reminder, this call is being recorded and all attendees are in a listen-only 00:00:10.795 -- 00:00:17.682 mode. We will open the call for questions and answers after our management's presentation. 00:00:17.682 -- 00:00:23.154 A webcast replay of today's conference call will be available on our website at lanternpharma.com 00:00:23.154 -- 00:00:28.185 shortly after the call. We issued a press release after market closed today, 00:00:28.185 -- 00:00:33.115 summarizing our financial results and progress across the company for the fourth quarter 00:00:33.115 -- 00:00:37.118 and year. Ended December 31, 2025. 00:00:38.482 -- 00:00:43.128 A copy of this release is available through our website at lanternpharma.com, 00:00:43.128 -- 00:00:47.093 where you will also find a link to the slides management we'll be referencing on today's 00:00:47.093 -- 00:00:52.159 call. We would like to remind everyone that remarks about future expectations, 00:00:52.159 -- 00:00:57.185 performance, estimates, and prospects constitute forward-looking statements for 00:00:57.185 -- 00:01:02.331 purposes of safe harbor provisions under the Private Securities Litigation Reform Act 00:01:02.331 -- 00:01:03.953 of 1995. 00:01:03.953 -- 00:01:09.760 Lantern Pharma cautions that these forward-looking statements are subject to risks 00:01:09.760 -- 00:01:14.826 and uncertainties that may cause actual results to differ materially from those 00:01:14.826 -- 00:01:16.608 anticipated. 00:01:16.608 -- 00:01:21.914 A number of factors could cause actual results to differ materially from those 00:01:21.914 -- 00:01:27.300 indicated by forward-looking statement...